A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

This study has been completed.

First Received: May 12, 2006 Last Updated: December 19, 2007 History of Changes

Sponsored by:	Alcon Research
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00326092

Purpose

The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension

Condition	Intervention	Phase
Open-Angle Glaucoma Ocular Hypertension	Drug: Brinzolamide/Timolol	Phase II

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Resource links provided by NLM:

Genetics Home Reference related topics: early-onset glaucoma

MedlinePlus related topics: Glaucoma High Blood Pressure

Drug Information available for: Timolol Azopt

Further study details as provided by Alcon Research:

Primary Outcome Measures:

Estimated Enrollment:	88
Study Start Date:	April 2006
Estimated Study Completion Date:	September 2006

Eligibility

Criteria

Inclusion Criteria:

Adults of either sex and any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00326092

Locations

United States, Texas
Fort Worth and Other Sites
Fort Worth, Texas, United States, 76134

Sponsors and Collaborators

Alcon Research

Investigators

Study Director:

Julia White

Study Director

More Information

No publications provided

Study ID Numbers:	C-05-49
Study First Received:	May 12, 2006
Last Updated:	December 19, 2007
ClinicalTrials.gov Identifier:	NCT00326092 History of Changes
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Carbonic Anhydrase Inhibitors
Brinzolamide
Glaucoma
Eye Diseases
Glaucoma, Open-Angle

Vascular Diseases
Timolol
Hypertension
Ocular Hypertension

Additional relevant MeSH terms:

Carbonic Anhydrase Inhibitors
Molecular Mechanisms of Pharmacological Action
Brinzolamide
Glaucoma
Eye Diseases
Glaucoma, Open-Angle

Vascular Diseases
Enzyme Inhibitors
Cardiovascular Diseases
Pharmacologic Actions
Ocular Hypertension
Hypertension

ClinicalTrials.gov processed this record on July 02, 2009